Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 38.31%24.55B | 19.97%14.09B | 25.36%7.41B | 22.65%26.08B | 21.57%17.75B | 31.83%11.74B | 46.70%5.91B | 33.52%21.26B | 46.94%14.6B | 74.51%8.91B |
| Refunds of taxes and levies | -48.75%252.15M | -39.60%215.04M | -51.11%123.65M | 21.74%715.44M | -2.15%491.98M | 1.31%356.01M | 1,208.27%252.93M | 52.51%587.66M | 145.55%502.8M | 221.50%351.42M |
| Cash received relating to other operating activities | -56.03%1.1B | 21.44%504.14M | 9.81%174.8M | 62.61%3.24B | 58.40%2.5B | -37.51%415.12M | 1.31%159.18M | 26.90%1.99B | 15.05%1.58B | 36.37%664.25M |
| Cash inflows from operating activities | 24.88%25.9B | 18.32%14.81B | 21.91%7.71B | 25.97%30.04B | 24.34%20.74B | 26.11%12.51B | 50.34%6.33B | 33.34%23.84B | 44.90%16.68B | 74.07%9.92B |
| Goods services cash paid | 53.42%21.25B | 60.00%13.25B | 81.65%6.56B | 31.21%19.93B | 24.37%13.85B | 11.88%8.28B | 9.78%3.61B | 12.30%15.19B | 33.54%11.14B | 44.27%7.4B |
| Staff behalf paid | 26.33%4.87B | 24.70%3.31B | 29.40%1.94B | 29.69%5.03B | 36.56%3.86B | 39.60%2.65B | 33.36%1.5B | 30.91%3.88B | 31.83%2.83B | 30.79%1.9B |
| All taxes paid | -9.20%1.31B | -21.36%891.34M | 13.09%494.21M | 17.86%1.97B | 31.61%1.44B | 51.81%1.13B | 57.60%437.01M | 21.98%1.67B | 36.74%1.09B | 84.24%746.61M |
| Cash paid relating to other operating activities | -11.81%1.03B | -27.40%555.01M | -18.23%441.46M | 107.33%1.53B | 140.68%1.17B | 220.02%764.5M | 207.60%539.88M | -1.46%738.91M | 16.27%486.47M | -4.72%238.89M |
| Cash outflows from operating activities | 40.09%28.47B | 40.31%18B | 55.01%9.44B | 32.51%28.46B | 30.73%20.32B | 24.73%12.83B | 25.08%6.09B | 15.42%21.48B | 32.83%15.54B | 42.11%10.28B |
| Net cash flows from operating activities | -713.01%-2.57B | -917.34%-3.19B | -834.01%-1.73B | -33.48%1.57B | -63.15%418.66M | 13.18%-313.7M | 135.60%235.51M | 424.89%2.37B | 695.00%1.14B | 76.48%-361.31M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | --480M | --0 | --0 | ---- | ---- | --0 | --0 | 567.70%2.55M | --2.55M | --2.55M |
| Cash received from returns on investments | --2.07M | --1.4M | --843.52K | --834.83K | ---- | --0 | --0 | ---- | ---- | ---- |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -88.86%740.74K | -78.88%734.88K | 364.12%240.88K | 2,290.34%6.67M | 190.01%6.65M | --3.48M | --51.9K | -57.81%278.93K | 512.95%2.29M | ---- |
| Net cash received from disposal of subsidiaries and other business units | ---- | --0 | --0 | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Cash received relating to other investing activities | --3.13M | --3.13M | --4.54M | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Cash inflows from investing activities | 7,210.13%485.93M | 51.15%5.26M | 10,741.18%5.63M | 165.26%7.5M | 37.23%6.65M | 36.39%3.48M | --51.9K | 171.18%2.83M | 1,195.32%4.84M | 763.42%2.55M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -39.75%546.71M | -49.42%337.57M | -26.97%191.54M | 3.34%2.05B | -36.49%907.44M | -22.43%667.34M | -38.98%262.26M | 40.56%1.98B | 73.11%1.43B | 39.47%860.28M |
| Cash paid to acquire investments | 776.33%718.88M | 1,063.27%197.84M | 1,554.49%209.56M | 128.56%166.77M | 23.85%82.03M | -73.79%17.01M | -71.79%12.67M | 380.35%72.97M | 661.41%66.24M | 830.95%64.9M |
| Net cash paid to acquire subsidiaries and other business units | --1.87B | --1.87B | --119.68M | -24.70%6.3M | ---- | --0 | --0 | --8.37M | --8.37M | --8.37M |
| Cash paid relating to other investing activities | ---- | --0 | --0 | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Cash outflows from investing activities | 216.69%3.13B | 251.19%2.4B | 89.43%520.78M | 7.66%2.22B | -34.19%989.48M | -26.69%684.35M | -42.40%274.92M | 44.78%2.06B | 80.25%1.5B | 49.66%933.54M |
| Net cash flows from investing activities | -169.39%-2.65B | -252.21%-2.4B | -87.42%-515.15M | -7.44%-2.21B | 34.42%-982.83M | 26.87%-680.87M | 42.41%-274.87M | -44.68%-2.06B | -79.75%-1.5B | -49.32%-930.99M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | -56.95%398.78M | -82.39%114.81M | 312.40%38.49M | 502.27%1.28B | 398.85%926.3M | 276.15%651.86M | -29.12%9.33M | 34.97%212.49M | 28.36%185.69M | 60.55%173.3M |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | -97.98%11.96M | ---- | --0 | 642.43%841.89M | 480.65%591.89M | 480.65%591.89M | --0 | --113.4M | --101.94M | --101.94M |
| Cash from borrowing | 1,447.30%8.94B | 1,345.25%7.76B | 268.69%935.39M | -73.91%709.43M | -71.62%577.71M | -66.75%536.91M | -63.76%253.71M | -33.02%2.72B | -49.35%2.04B | -11.23%1.61B |
| Cash received relating to other financing activities | --19.38K | --0 | --0 | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Cash inflows from financing activities | 520.85%9.34B | 562.41%7.87B | 270.24%973.88M | -32.14%1.99B | -32.30%1.5B | -33.52%1.19B | -63.12%263.04M | -30.48%2.93B | -46.65%2.22B | -7.21%1.79B |
| Borrowing repayment | 234.78%2.14B | 176.83%1.61B | -79.56%61.19M | -30.51%577.12M | 181.21%639.19M | 155.54%580.86M | 41.78%299.4M | 36.92%830.48M | -62.52%227.3M | -62.52%227.3M |
| Dividend interest payment | 38.82%801.81M | -16.77%105.36M | -17.26%52.3M | 58.62%614.85M | 67.29%577.59M | 80.18%126.58M | 110.40%63.21M | 60.75%387.63M | 130.92%345.26M | 144.77%70.25M |
| -Including:Cash payments for dividends or profit to minority shareholders | -27.96%30.36M | -77.51%9.48M | -32.31%9.48M | 493.25%43.04M | 486.06%42.14M | 486.06%42.14M | --14M | -91.82%7.26M | -70.52%7.19M | -70.52%7.19M |
| Cash payments relating to other financing activities | 393.03%164.28M | 422.36%135.21M | -68.82%4.76M | -13.75%56.93M | 90.18%33.32M | 150.10%25.88M | 859.48%15.26M | 170.61%66M | 22.09%17.52M | 140.94%10.35M |
| Cash outflows from financing activities | 148.46%3.11B | 152.08%1.85B | -68.71%118.25M | -2.74%1.25B | 111.85%1.25B | 138.17%733.32M | 55.62%377.86M | 47.25%1.28B | -23.41%590.08M | -51.86%307.9M |
| Net cash flows from financing activities | 2,354.39%6.23B | 1,223.08%6.03B | 845.16%855.63M | -55.06%740.31M | -84.44%253.9M | -69.23%455.45M | -124.41%-114.83M | -50.75%1.65B | -51.92%1.63B | 14.97%1.48B |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 84.80%-2.62M | -60.17%2.34M | -156.17%-939.32K | -62.94%5.15M | -159.60%-17.26M | -84.46%5.88M | 117.19%1.67M | -62.16%13.9M | -48.95%28.96M | 69.06%37.82M |
| Net increase in cash and cash equivalents | 409.89%1.01B | 182.29%438.81M | -810.85%-1.39B | -94.57%106.9M | -125.24%-327.53M | -336.05%-533.24M | 77.51%-152.51M | 59.89%1.97B | -46.50%1.3B | 126.58%225.9M |
| Add:Begin period cash and cash equivalents | 0.31%12.39B | 0.31%12.39B | 0.40%12.4B | 19.17%12.23B | 20.32%12.35B | 20.32%12.35B | 20.32%12.35B | 13.63%10.26B | 13.63%10.26B | 13.63%10.26B |
| End period cash equivalent | 11.49%13.4B | 8.55%12.82B | -9.73%11.01B | 0.87%12.34B | 3.98%12.02B | 12.65%11.81B | 27.25%12.19B | 19.17%12.23B | 0.90%11.56B | 28.19%10.49B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianji International Accounting Firm (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.